Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
National, observational, cross sectional survey evaluating the atrial fibrillation management and cardiovascular risk profile of AF patient. Sanofi Ongoing N/A 4 DIREG_L_05290 King Khalid University Hospital (Riyadh)
Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled Sanofi Ongoing Lantus® 4 Lantu_C_02762 King Abdulaziz University Hospital (Jeddah), King Fahad University Hospital (Al-Khobar)
Registry in the management of Acute Diarrhea in Children : Observational study in Daily practice Sanofi Ongoing N/A 4 DIREG_R_06373 King Fahad Medical City (Riyadh)
International Diabetes Management Practice Study - IDMPS Sanofi Ongoing N/A 4 DIREG_R_05168 King Fahad Hospital (Jeddah)
Unmet needs in allergic rhinitis: International Survey on Mangment of Allergic Rhinitis by Physician and Patient. Sanofi Ongoing N/A 4 DIREG_R_06411 Soliman Fakeeh Hospital (Jeddah)
The Influence of a rapid relief of gastro esophageal reflux disease (GERD) symptoms on the quality of life and patient satisfaction after initiating treatment with a Proton Pump Inhibitor. Sanofi Ongoing N/A 4 DRIEG_L_05705 University District Hospital (Jeddah)
Venous Thromboembolic Risk Assessment of Post-Partum Females in Saudi Arabia Utilizing Royal College of Obstetrics and Gynecology Risk Assessment Model Sanofi Ongoing N/A 4 DIREG_L_06410 King Abdulaziz University Hospital (Jeddah)
An observational registry improving Control of Hypertension and Achieving Normalization Goal Earlier Sanofi Ongoing N/A 4 DIREG_L_05059 Erfan & Bagedo General Hospital (Jeddah)
International Diabetes Management Practices Study (Wave 5) Sanofi Ongoing N/A 4 DIREG_R_05941 King Fahad Hospital (Jeddah)
An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia Sanofi Ongoing Levofloxacin 4 LEVOF_L_05172 Erfan & Bagedo General Hospital (Jeddah)
View 661 - 670 From 741